# MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53424
Published: 2026-11-11T00:12:27.000Z
Updated: 2026-11-11T00:12:27.000Z
Section: Business

> The company expects its $481.6 million in cash and investments to support operations into 2029.

MBX Biosciences posted a GAAP loss of $1.29 per share for the third quarter. The company expects its $481.6 million in cash and investments to support operations into 2029.